#buys #bullish #WallStreet #analysts

$ADC $FIBO $IMGN $MEDP $PZZA $WMT $YETI

These are all Buys if you can manage the risk.

Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy

Below is our list for Monday, 5 October, as follows:

Agree Realty Corp. (NYSE:ADC) was resumed in coverage at Raymond James with a Strong Buy rating and an 82 price target. The consensus target is at 76.

Fortress Biotech Inc. (NASDAQ:FBIO) was started with a Buy rating with a 9 price target at Benchmark. The slightly higher consensus target is 9.80.

ImmunoGen Inc. (NASDAQ:IMGN) was raised to Buy from Neutral at Guggenheim. The company is focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer. Its 52-wk trading range is 1.85 – 3.07, and the consensus price target is 6.96.

Medpace Holdings Inc. (NASDAQ:MEDP) was raised to Buy from Hold at Truist, which also set a 135 price. The consensus target price is 119.20.

Papa John’s International Inc. (NASDAQ:PZZA) was started with a Buy rating and a 110 price target at Loop Capital. The consensus target for the pizza giant is at 106.21

Walmart Inc. (NYSE:WMT) was raised to Buy from Hold at DZ Bank, which also set a 157.50 price target. The consensus target is at 146.09.

Yeti Holdings Inc. (NYSE:YETI): this high-end cooler firm that has expanded its portfolio to more everyday items. Shares have a consensus price target at 56.50.

Have a healthy weekend, Keep the Faith!

  #ADC, #analysts, #avoid, #buy, #Fibo, #heffx, #hold, #IMGN, #MEDP, #PZZA, #sell, #trade, #Wall Street, #WMT, #YETI

The following two tabs change content below.

• Bio
• Latest Posts

Paul Ebeling

Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   

Latest posts by Paul Ebeling (see all)

• Senate Parliamentarian: Democrats Cannot Include $15/hr Minimum Wage in COVID Relief Bill - February 25, 2021
• Sitting on a Cash Pile 11.0? Early Call: News and Business Information Services Giant Breaks Out - February 25, 2021
• Wall Street’s Key Stock Analysts Research Report, All Buys - February 25, 2021